{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T18:29:45Z","timestamp":1795026585123,"version":"4.10.2"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:p>Neuroendocrine carcinomas (NECs) are rare, but aggressive malignant tumors of the female genital tract, especially in the uterine the cervix. Beside histologic morphology, positivity of neuroendocrine markers with immunohistochemistry plays an important role in diagnosis of NECs. Insulinoma-associated protein 1 (INSM1) is a novel marker reported to be widely expressed in a variety of neuroendocrine tumors. A previous study also suggested INSM1 has superior performance to conventional neuroendocrine markers in cervical NECs. In our present study, comparison between immunomarkers was performed in female genital tract NECs. Forty-nine patients with gynecologic NECs (4 vagina, 39 cervix, 5 endometrium, 1 ovary) were included from 1993 to 2019 at our center. Immunohistochemistry was performed with INSM1, CD56, synaptophysin (SYN), chromogranin-A (CgA), and thyroid transcription factor 1 (TTF1). The results show INSM1 has superior sensitivity and intensity compared with CD56, SYN, CgA, and TTF1 in cervical small cell NECs, but not in large cell NECs. In contrast to cervical NECs, INSM1 immunohistochemistry shows only focal and weak staining in endometrial NECs. Our result suggested INSM1 is a sensitive marker which can be used as first-line test in histologic suspicious cervical cases, especially small cell NECs. However, negative INSM1 stain does not exclude the possibility of NECs. In endometrial NECs, conventional panel with CD56, SYN, CgA has better diagnostic performance than INSM1 alone.<\/jats:p>","DOI":"10.1097\/pgp.0000000000000722","type":"journal-article","created":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T13:32:41Z","timestamp":1608039161000},"page":"452-459","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Insulinoma-associated Protein 1 Expression and Its Diagnostic Significance in Female Genital Tract Neuroendocrine Carcinomas"],"prefix":"10.1097","volume":"40","author":[{"given":"Ching-Heng","family":"Ting","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao-Yeuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pao-Shu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,12,14]]},"reference":[{"key":"R1-20250802","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/PAS.0b013e3181d1d457","article-title":"An immunohistochemical study of cervical neuroendocrine carcinomas: neoplasms that are commonly TTF-1 positive and which may express CK20 and P63","volume":"34","author":"McCluggage","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R3-20250802","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/nar\/30.4.1038","article-title":"Neuroendocrine differentiation factor, IA-1, is a transcriptional repressor and contains a specific DNA-binding domain: identification of consensus IA-1 binding sequence","volume":"30","author":"Breslin","year":"2002","journal-title":"Nucleic Acids Res"},{"key":"R4-20250802","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1016\/j.ajpath.2015.08.018","article-title":"Insulinoma-associated protein 1 is a crucial regulator of neuroendocrine differentiation in lung cancer","volume":"185","author":"Fujino","year":"2015","journal-title":"Am J Pathol"},{"key":"R5-20250802","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1101\/gad.381806","article-title":"The zinc-finger factor Insm1 (IA-1) is essential for the development of pancreatic beta cells and intestinal endocrine cells","volume":"20","author":"Gierl","year":"2006","journal-title":"Genes Dev"},{"key":"R6-20250802","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1096\/fj.08-125971","article-title":"Structure, expression, and biological function of INSM1 transcription factor in neuroendocrine differentiation","volume":"23","author":"Lan","year":"2009","journal-title":"FASEB J"},{"key":"R7-20250802","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/jnen\/nly014","article-title":"INSM1 expression is frequent in primary central nervous system neoplasms but not in the adult brain parenchyma","volume":"77","author":"Ames","year":"2018","journal-title":"J Neuropathol Exp Neurol"},{"key":"R8-20250802","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/his.13899","article-title":"INSM1 expression in primary and metastatic neuroendocrine neoplasms of the gastrointestinal and pancreatobiliary tracts","volume":"75","author":"Gonzalez","year":"2019","journal-title":"Histopathology"},{"key":"R9-20250802","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/PAI.0000000000000824","article-title":"Insulinoma-associated protein 1 (INSM1) expression in small cell neuroendocrine carcinoma of the urinary tract","volume":"9","author":"Kim","year":"2020","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R10-20250802","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1097\/PAS.0000000000001136","article-title":"INSM1 is more sensitive and interpretable than conventional immunohistochemical stains used to diagnose merkel cell carcinoma","volume":"42","author":"Lilo","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R11-20250802","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/PAS.0000000000001037","article-title":"INSM1 is a sensitive and specific marker of neuroendocrine differentiation in head and neck tumors","volume":"42","author":"Rooper","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R12-20250802","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1097\/PAS.0000000000000916","article-title":"INSM1 demonstrates superior performance to the individual and combined use of synaptophysin, chromogranin and CD56 for diagnosing neuroendocrine tumors of the thoracic cavity","volume":"41","author":"Rooper","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R13-20250802","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1309\/AJCPGZWXXBSNL4VD","article-title":"INSM1: a novel immunohistochemical and molecular marker for neuroendocrine and neuroepithelial neoplasms","volume":"144","author":"Rosenbaum","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"R14-20250802","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s12022-018-9559-y","article-title":"Expression of insulinoma-associated protein 1 (INSM1) and orthopedia homeobox (OTP) in tumors with neuroendocrine differentiation at rare sites","volume":"30","author":"Roy","year":"2019","journal-title":"Endocr Pathol"},{"key":"R15-20250802","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.humpath.2018.05.014","article-title":"Insulinoma-associated protein 1 is a novel sensitive and specific marker for small cell carcinoma of the prostate","volume":"79","author":"Xin","year":"2018","journal-title":"Hum Pathol"},{"key":"R16-20250802","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/modpathol.2017.189","article-title":"INSM1 expression and its diagnostic significance in extraskeletal myxoid chondrosarcoma","volume":"31","author":"Yoshida","year":"2018","journal-title":"Mod Pathol"},{"key":"R17-20250802","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.ygyno.2016.11.020","article-title":"A new marker, insulinoma-associated protein 1 (INSM1), for high-grade neuroendocrine carcinoma of the uterine cervix: analysis of 37 cases","volume":"144","author":"Kuji","year":"2017","journal-title":"Gynecol Oncol"},{"key":"R18-20250802","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/PAI.0000000000000715","article-title":"Insulinoma-associated protein 1 (INSM1) in thoracic tumors is less sensitive but more specific compared with synaptophysin, chromogranin A, and CD56","volume":"3","author":"Kriegsmann","year":"2020","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R19-20250802","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41379-018-0122-7","article-title":"Insulinoma-associated protein 1 (INSM1) is a sensitive and highly specific marker of neuroendocrine differentiation in primary lung neoplasms: an immunohistochemical study of 345 cases, including 292 whole-tissue sections","volume":"32","author":"Mukhopadhyay","year":"2019","journal-title":"Mod Pathol"},{"key":"R20-20250802","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.humpath.2018.10.016","article-title":"Triple marker composed of p16, CD56, and TTF-1 shows higher sensitivity than INSM1 for diagnosis of pulmonary small cell carcinoma: proposal for a rational immunohistochemical algorithm for diagnosis of small cell carcinoma in small biopsy and cytology specimens","volume":"85","author":"Svajdler","year":"2019","journal-title":"Hum Pathol"},{"key":"R22-20250802","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.1200\/JCO.2003.11.069","article-title":"Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis","volume":"21","author":"Hirsch","year":"2003","journal-title":"J Clin Oncol"},{"key":"R23-20250802","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.humpath.2019.12.002","article-title":"Immunohistochemistry in the diagnosis and classification of neuroendocrine neoplasms: what can Brown do for you?","volume":"96","author":"Bellizzi","year":"2020","journal-title":"Hum Pathol"},{"key":"R24-20250802","first-page":"5","article-title":"Thyroid transcription factor-1: immunohistochemical evaluation in pulmonary neuroendocrine tumors","volume":"12","author":"Folpe","year":"1999","journal-title":"Mod Pathol"},{"key":"R25-20250802","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.humpath.2005.04.007","article-title":"Thyroid transcription factor 1 expression in small cell carcinoma of the urinary bladder: an immunohistochemical profile of 44 cases","volume":"36","author":"Jones","year":"2005","journal-title":"Hum Pathol"},{"key":"R26-20250802","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/jso.24393","article-title":"Immunophenotypic and prognostic analysis of PAX8 and TTF-1 expressions in neuroendocrine carcinomas of thymic origin: a comparative study with their pulmonary counterparts","volume":"114","author":"Bi","year":"2016","journal-title":"J Surg Oncol"},{"key":"R27-20250802","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.anndiagpath.2018.09.005","article-title":"The expression of TTF-1, CDX2 and ISL1 in 74 poorly differentiated neuroendocrine carcinomas","volume":"37","author":"Lee","year":"2018","journal-title":"Ann Diagn Pathol"}],"container-title":["International Journal of Gynecological Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PGP.0000000000000722","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:04:30Z","timestamp":1754161470000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PGP.0000000000000722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,14]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/pgp.0000000000000722","relation":{},"ISSN":["0277-1691"],"issn-type":[{"value":"0277-1691","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,14]]}}}